| Title : Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study - Ceccanti_2022_Front.Pharmacol_13_982434 |
| Author(s) : Ceccanti M , Libonati L , Ruffolo G , Cifelli P , Moret F , Frasca V , Palma E , Inghilleri M , Cambieri C |
| Ref : Front Pharmacol , 13 :982434 , 2022 |
| Abstract : Ceccanti_2022_Front.Pharmacol_13_982434 |
| ESTHER : Ceccanti_2022_Front.Pharmacol_13_982434 |
| PubMedSearch : Ceccanti_2022_Front.Pharmacol_13_982434 |
| PubMedID: 36052140 |
Ceccanti M, Libonati L, Ruffolo G, Cifelli P, Moret F, Frasca V, Palma E, Inghilleri M, Cambieri C (2022)
Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study
Front Pharmacol
13 :982434
Ceccanti M, Libonati L, Ruffolo G, Cifelli P, Moret F, Frasca V, Palma E, Inghilleri M, Cambieri C (2022)
Front Pharmacol
13 :982434